Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 30, 2026

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Contribution of HPLC mass screening for neuroblastoma to a decrease in mortality.

M Nishi1, T Takeda, Y Hatae

  • 1Dept. of Public Health, Sapporo Medical University, Hakkaido, Japan.

Journal of Experimental & Clinical Cancer Research : CR
|June 20, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Involvement of brown adipose tissue in subcutaneous fat necrosis of the newborn.

Dermatology (Basel, Switzerland)·2011
Same author

Phase I/II study of irinotecan and UFT for advanced or metastatic colorectal cancer.

Anticancer research·2007
Same author

Induction of osteoclast-like cells derived from the synovial lavage fluids of patients with temporomandibular joint disorders.

Osteoarthritis and cartilage·2006
Same author

Is the mass screening for neuroblastoma ineffective?

Journal of experimental & clinical cancer research : CR·2004
Same author

The use of an osseointegrated implant for orthodontic anchorage to a Class II Div 1 malocclusion.

The Bulletin of Tokyo Dental College·2002
Same author

Expression of Ca(2+)-activated K(+) channels, SK3, in the interstitial cells of Cajal in the gastrointestinal tract.

American journal of physiology. Cell physiology·2001
Same journal

Extracellular vesicle-mediated GALNT1/RPRD1A glycosylation axis drives immune escape and peritoneal metastasis in gastric cancer.

Journal of experimental & clinical cancer research : CR·2026
Same journal

NHE7-Driven endoplasmic reticulum stress signaling transmission promotes malignant progression of endometrial cancer via c-Fos/PRSS1/ERP27 axis.

Journal of experimental & clinical cancer research : CR·2026
Same journal

Correction: Nanovaccines with ferroptosis, necroptosis and STING-activation for synergistic immunotherapy.

Journal of experimental & clinical cancer research : CR·2026
Same journal

Adipocyte-rich microenvironment promotes TNBC progression through SIRT6-associated ACSL5 dysregulation and lipid storage-associated phenotypes.

Journal of experimental & clinical cancer research : CR·2026
Same journal

Correction: Copy number amplification-induced overexpression of lncRNA LOC101927668 facilitates colorectal cancer progression by recruiting hnRNPD to disrupt RBM47/p53/p21 signaling.

Journal of experimental & clinical cancer research : CR·2026
Same journal

Decoding glioblastoma evolution and heterogeneity through mechanistic modeling: implications for clinical translation.

Journal of experimental & clinical cancer research : CR·2026
See all related articles

High-performance liquid chromatography (HPLC) mass screening for neuroblastoma in infants significantly reduces mortality rates. This study shows HPLC screening contributes to approximately a 50% decrease in deaths from adrenal neuroblastomas.

Area of Science:

  • Pediatric Oncology
  • Public Health Screening
  • Biomarker Detection

Background:

  • Neuroblastoma is a significant cause of cancer-related mortality in young children.
  • Early detection methods are crucial for improving survival rates.
  • Assessing the impact of mass screening programs on mortality is essential for public health policy.

Purpose of the Study:

  • To estimate the contribution of high-performance liquid chromatography (HPLC) mass screening for neuroblastoma to the reduction in childhood mortality.
  • To quantify the impact of HPLC screening on deaths from adrenal gland neoplasms in infants.

Main Methods:

  • Analysis of mortality data for adrenal gland neoplasms (ICD 9: 1940, ICD 10: C74) in Japanese children aged 1-4 years across birth cohorts (1979-1984, 1985-1988, 1989-1992).

More Related Videos

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Experiment Videos

Last Updated: Jun 30, 2026

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

  • Estimation of infant screening rates using HPLC based on Ministry of Health and Welfare reports and Japanese Society for Mass-screening data.
  • Statistical modeling using simultaneous equations to determine the independent contribution of HPLC screening versus other factors to mortality reduction.

    • Main Results:

    • Mortality rates for infants born in 1989-1992, with 77.8% HPLC screening coverage, were 1.73 per 100,000 live births, approximately half the rate of the 1979-1984 cohort (3.26) with minimal screening.
    • Calculations indicated that HPLC screening accounted for a 50.41% reduction in deaths (x=0.5041), while other factors contributed 7.57% (y=0.0757).
    • Observed deaths in the 1985-1988 and 1989-1992 cohorts were significantly lower than expected without HPLC screening.

    Conclusions:

    • HPLC mass screening targeting infants at 6 months of age is highly effective in reducing mortality from adrenal neuroblastomas.
    • The study demonstrates a substantial impact of HPLC screening, contributing to nearly a 50% decrease in deaths from this childhood cancer.
    • Implementation and expansion of HPLC screening programs are recommended for improved pediatric cancer outcomes.